Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer

[1]  Zhiping Hu,et al.  UBIAD1 alleviates ferroptotic neuronal death by enhancing antioxidative capacity by cooperatively restoring impaired mitochondria and Golgi apparatus upon cerebral ischemic/reperfusion insult , 2022, Cell & Bioscience.

[2]  Hae-June Lee,et al.  Loss of FBXL14 promotes mesenchymal shift and radioresistance of non-small cell lung cancer by TWIST1 stabilization , 2021, Signal Transduction and Targeted Therapy.

[3]  R. Herbst,et al.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC , 2021, Nature Reviews Clinical Oncology.

[4]  Zuoren Yu,et al.  Reck-Notch1 Signaling Mediates miR-221/222 Regulation of Lung Cancer Stem Cells in NSCLC , 2021, Frontiers in Cell and Developmental Biology.

[5]  Shuo Zhang,et al.  EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non-small cell lung cancer cells , 2021, Oncology reports.

[6]  Qinglian He,et al.  Cancer stem cells in colorectal cancer and the association with chemotherapy resistance , 2021, Medical Oncology.

[7]  Haiping Zhao,et al.  PBK/TOPK: A Therapeutic Target Worthy of Attention , 2021, Cells.

[8]  Qiming Wang,et al.  MEK inhibitors for the treatment of non-small cell lung cancer , 2021, Journal of Hematology & Oncology.

[9]  B. Kong,et al.  PBK promotes aggressive phenotypes of cervical cancer through ERK/c‐Myc signaling pathway , 2020, Journal of cellular physiology.

[10]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[11]  S. Jang,et al.  Prognostic Significance of CHIP and RIPK3 in Non-Small Cell Lung Cancer , 2020, Cancers.

[12]  R. Xiang,et al.  WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC , 2020, Signal Transduction and Targeted Therapy.

[13]  C. Diaconu,et al.  Gastrointestinal cancer stem cells as targets for innovative immunotherapy , 2020, World journal of gastroenterology.

[14]  Hwan-Woo Park,et al.  PBK attenuates paclitaxel‐induced autophagic cell death by suppressing p53 in H460 non‐small‐cell lung cancer cells , 2020, FEBS open bio.

[15]  M. Di Nicola,et al.  Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure , 2020, Cells.

[16]  M. Lleonart,et al.  Insights into new mechanisms and models of cancer stem cell multidrug resistance. , 2020, Seminars in cancer biology.

[17]  Di Chen,et al.  The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions , 2020, Annals of the New York Academy of Sciences.

[18]  G. Bao,et al.  PDZ-Binding Kinase-Dependent Transcriptional Regulation of CCNB2 Promotes Tumorigenesis and Radio-Resistance in Glioblastoma , 2019, Translational oncology.

[19]  Wei Zhou,et al.  TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness , 2019, Signal Transduction and Targeted Therapy.

[20]  M. Najafi,et al.  Cancer stem cell (CSC) resistance drivers. , 2019, Life sciences.

[21]  S. Alberti,et al.  Abandoning the Notion of Non-Small Cell Lung Cancer. , 2019, Trends in molecular medicine.

[22]  Z. Ding,et al.  Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  F. Islam,et al.  Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy. , 2019, Anti-cancer agents in medicinal chemistry.

[24]  S. Skvortsov,et al.  Therapy resistance mediated by cancer stem cells. , 2018, Seminars in cancer biology.

[25]  C. Lin,et al.  Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities. , 2018, Chest.

[26]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[27]  F. Askin,et al.  Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. , 2017, Seminars in cancer biology.

[28]  D. Gomez,et al.  Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer. , 2017, Practical radiation oncology.

[29]  Ming Yan,et al.  Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer , 2017, Experimental cell research.

[30]  Min Young Kim,et al.  Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation , 2017, Molecular Cancer.

[31]  Wang Qingfeng,et al.  CHIP involves in non-small cell lung cancer prognosis through VEGF pathway. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  S. Senan,et al.  A critical review of recent developments in radiotherapy for non-small cell lung cancer , 2016, Radiation Oncology.

[33]  Li Yuan,et al.  Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity , 2016, Oncotarget.

[34]  F. Pajonk,et al.  Cancer stem cells, cancer cell plasticity and radiation therapy. , 2015, Seminars in cancer biology.

[35]  K. Kimura,et al.  Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells. , 2014, Biochemical and biophysical research communications.

[36]  A. Nesvizhskii,et al.  GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug , 2014, Oncogene.

[37]  Tao Xu,et al.  A Proteomics Strategy to Identify Substrates of LNX, a PDZ Domain Containing E3 Ubiquitin Ligase , 2011, Journal of proteome research.

[38]  J. Martin,et al.  Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[39]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[40]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[41]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.